| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,661 | 8,200 | 7,700 | 7,729 | | Cost of Revenue | 2,148 | 2,192 | 2,290 | 2,365 | | | Gross Profit |
-
| 6,008 | 5,410 | 5,364 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,403 | 4,813 | 4,845 | 4,378 | | Non Recurring | 1,085 |
-
|
-
| 4,458 | | Others | 1,620 | 2,541 | 2,217 | 3,990 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,346) | (1,652) | (7,462) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (595) | (1,346) | (1,652) | (7,462) | | Interest Expense | 78 | 106 | 103 | 121 | | Income Before Tax | (673) | (1,452) | (1,755) | (7,583) | | Income Tax Expense |
-
|
-
| 23 | 2,036 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (673) | (1,452) | (1,778) | (9,619) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (673) | (1,452) | (1,778) | (9,619) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($673) | ($1,452) | ($1,778) | ($9,619) |
|
0.51% Nasdaq 
Income Statement
